JAMA Oncology : Impact Factor & More
eISSN: 2374-2445pISSN: 2374-2437
Share this on:
Key Metrics
CiteScore 
44.4
Eigenfactor
0.05 - 0.1
Impact Factor
>= 25
Scite Index
0.85 5-Year SI
SJR
Q1Oncology
SNIP
7.17
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JAMA Oncology
JAMA Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | AMER MEDICAL ASSOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JAMA Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JAMA Oncology
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial.
- 16 May 2026
- JAMA oncology
Generalizability and Fairness in Deploying AI for Lung Cancer Biomarker Prediction—Reply
- 14 May 2026
- JAMA Oncology
Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer
- 14 May 2026
- JAMA Oncology
Generalizability and Fairness in Deploying AI for Lung Cancer Biomarker Prediction
- 14 May 2026
- JAMA Oncology
War Outside the Window—Reflections From Beirut
- 14 May 2026
- JAMA Oncology
Temporal Trends in Lung Cancer Cases Diagnosed at Early Stage
- 14 May 2026
- JAMA Oncology
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial.
- 16 May 2026
- JAMA oncology
Generalizability and Fairness in Deploying AI for Lung Cancer Biomarker Prediction—Reply
- 14 May 2026
- JAMA Oncology
Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer
- 14 May 2026
- JAMA Oncology
Generalizability and Fairness in Deploying AI for Lung Cancer Biomarker Prediction
- 14 May 2026
- JAMA Oncology
War Outside the Window—Reflections From Beirut
- 14 May 2026
- JAMA Oncology
Temporal Trends in Lung Cancer Cases Diagnosed at Early Stage
- 14 May 2026
- JAMA Oncology
FAQs on JAMA Oncology
How long has JAMA Oncology been actively publishing? 
What is the publishing frequency of JAMA Oncology?
How many articles did JAMA Oncology publish last year?
What is the eISSN & pISSN for JAMA Oncology?
What is Citescore for JAMA Oncology?
What is SNIP score for JAMA Oncology?
What is the SJR for JAMA Oncology?
Who is the publisher of JAMA Oncology?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations